Endothelial Akt Signaling Is Rate-Limiting for Rapamycin Inhibition of Mouse Mammary Tumor Progression
Thuy L. Phung, Laura E. Benjamin(Beth Israel Deaconess Medical Center)
Cited by 53
Related Papers
Rapamycin Inhibition of the Akt/mTOR Pathway Blocks Select Stages of VEGF-A <sup>164</sup> –Driven Angiogenesis, in Part by Blocking S6Kinase
|Arteriosclerosis Thrombosis and Vascular Biology|2009|100